Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

QualityMetric is now an IQVIA Business: click here for more information on the IQVIA COAs available for licensing

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 53,000,000+ Global Survey administrations, 48,000+ Peer-reviewed articles across 100+ conditions, 200+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW

HIT-6 NEW COAS IN ONCOLOGY GUIDE

QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.

Read the Guide

News

03.21.24

Advancing Metabolic Disorder Research with Patient-Reported Outcomes

Assessing health-related quality of life (HRQoL) offers a significant amount of information on a person’s physical, mental, emotional and social well-being, and it can serve as a multifaceted metric in examining endocrine and metabolic disorders. As more healthcare professionals and researchers adopt a patient-centered approach to clinical research and care, they increasingly turn to patient-reported outcomes (PROs) as a method of capturing HRQoL.

05.14.24

Advancing Women’s Health Research: The Role of Patient-Reported Outcome Measures

Advancing Women’s Health Research: The Role of Patient-Reported Outcome Measures The healthcare industry has long faced a shortage of impactful research and treatments that specifically target current issues in women’s health, from breast and cervical cancers, to maternal health and menopause-related conditions, to autoimmune diseases and mental health challenges. Making progress on women’s health research […]

Read More
04.12.24

The Benefits of Using PROs in Vaccine Research & Development

The Benefits of Using PROs in Vaccine Research & Development As healthcare systems face multiple epidemics of flu, pneumonia, respiratory syncytial virus (RSV), and COVID infections, the industry is racing to research and develop vaccines that can help safeguard public health. The RSV vaccine market is expected to grow by an estimated $4 billion USD […]

Read More
03.18.24

QualityMetric (QM)—an IQVIA business, Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats

HITRUST certification validates QualityMetric is operating leading security practices to protect sensitive healthcare Information. Rhode Island, March 18, 2024 — QualityMetric (QM)—an IQVIA business, a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO)—has announced its Smart Measurement System has earned the recent achievement of certified status by HITRUST for information […]

Read More
01.29.24

Using PRO Measures in Amyloidosis Research

Using PRO Measures in Amyloidosis Research Amyloidosis refers to a group of rare diseases caused by the buildup of misfolded proteins in various tissues and organs in the body, often leading to organ damage and impaired quality of life. 1Given the rareness of systemic amyloidosis, there can be limited opportunities to gather data on the […]

Read More
12.19.23

LunaPBC and QualityMetric Partner on New Patient-Reported Outcome Instrument Development Initiative for Oncology

QualityMetric, an IQVIA business (QM), has contracted with LunaPBC to build a patient-driven oncology instrument for measuring the impacts on physical functioning across many cancers.

Read More
10.27.23

Amyloidosis Research Consortium (ARC) and QualityMetric (QM) Introduce the ATTR-QOL Questionnaire

QualityMetric (QM), a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO), has announced its partnership with the Amyloidosis Research Consortium (ARC) in supporting the licensing and use of the Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL), a patient-reported outcome (PRO) survey specific to ATTR amyloidosis.

Read More
09.14.23

QualityMetric Presentations During ISOQOL 2023 Conference

Join the QualityMetric science team for several exciting presentations at the 30th Annual ISOQOL Conference in Calgary, Alberta, Canada, from October 18th through the 21st. This year’s conference theme, Quality of Life, focuses on identifying and overcoming the barriers that limit the use of patient-reported outcomes (PROs) in everyday patient care. QualityMetric’s scientists are well-versed in this area of our work and aim to share best practices, tips and more in their presentations throughout ISOQOL 2023. We hope to see you at one of the following sessions!

Read More
09.11.23

Integrating PROMs into Pediatric Clinical Practice & Research

Integrating PROMs into Pediatric Clinical Practice & Research Healthcare for children has been improving drastically over the past century and beyond, and we’ve seen much lower rates of infectious diseases thanks to the advent of vaccines and modern medicine.1 As a result, this reduction in illness has led to better health-related quality of life (HRQoL) […]

Read More
06.23.23

Importance of PRO Selection for Medical Device Regulation

Importance of PRO Selection for Medical Device Regulation Navigating the regulatory process to build product label and marketing claims can be difficult, especially when it comes to selecting endpoints that generate the right type of evidence to support those claims. For this reason selecting the right patient-reported outcome (PRO) instrument is essential to whether for […]

Read More
04.14.23

QM Presentations During ISPOR Boston 2023

  QualityMetric Scientist Presenting During ISPOR Boston 2023 Don’t miss the informative sessions with QM scientists during the upcoming conference hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) this May in Boston. A Time Trade-Off Study to Estimate Respiratory Syncytial Virus (RSV) Related Utility Values for Older Adults (OA) in the Unites […]

Read More
04.12.23

QualityMetric Acquires HealthActCHQ

Johnston, Rhode Island, April 12, 2023 — QualityMetric (QM), a global leader in measuring patient health in clinical trials and in real world settings announced today its acquisition of HealthActCHQ’s (HACHQ) portfolio of internationally recognized child and infant parent and patient-reported outcome (PRO) measurement tools, including Child Health Questionnaires; CHQ-PF50, CHQ-PF28, CHQ-CF87 and CHQ-CF45, and […]

Read More
01.06.23

QualityMetric Statement of GDPR Compliance Status

Rhode Island, January 9, 2023 — QualityMetric (QM), a leading global technology-enabled provider of patient-reported outcome (PRO) and clinical outcome assessment (COA) surveys and scientific consulting services, has reconfirmed its commitment to comply with GDPR (both EU General Data Protection Regulation 2016/679 and its UK counterpart). These regulations are designed to provide individuals more control […]

Read More
11.10.22

Measuring Health-Related Quality of Life with PMSIS

Measuring Health-Related Quality of Life with PMSIS™ The healthcare industry has historically suffered from a low volume of valuable research and available treatments that address women’s health issues. One area particularly unexplored is premenstrual syndrome (PMS), and by extension, premenstrual dysphoric disorder (PMDD). A majority of women of reproductive age experience physical or psychological discomfort […]

Read More
11.09.22

What’s Trending in PROs: Reference Values

  What’s Trending in PROs: Reference Values Patient-reported outcomes (PROs) are increasingly valued in clinical trial research and treatment delivery as a reliable method of determining a patient’s current mental, emotional, or physical state relative to a variety of diseases and conditions. With health status reports coming directly from the patient rather than outsider interpretations […]

Read More
10.20.22

QM Contributing to Health Economics & Outcomes Research at ISPOR Europe 2022

QualityMetric is sharing new insights surrounding its SF-6Dv2 Health Utility Survey at an upcoming conference hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). On Tuesday, November 8th, at ISPOR Europe 2022 in Vienna, Austria, QM statistician Regina Rendas-Baum will offer insight on the development of the SF-6Dv2, a unique patient-reported outcomes (PRO) […]

Read More
09.30.22

QM is Ready to Redefine Boundaries at ISOQOL 2022

Join the QualityMetric science team for three presentations you won’t want to miss during this year’s ISOQOL Conference.    Development of Daily Diary Measures for Derivation of Endpoints in Clinical Trials Michelle White, Vice President, Consulting Science Services & Senior Scientist, QualityMetric will present: Wednesday, October 19th 10:30am-12:00pm (CEST) During the Industry Special Interest Group […]

Read More
09.26.22

Interpreting Headache Impact Test (HIT-6) Scores: Illuminating an Invisible Illness

Headaches and migraines do more than just hurt your head. They can severely impair patients’ ability to work and live in peace. For example, 23% of people with chronic migraines decrease their work hours, and 78% report that headaches adversely affect their children’s activities.1 As one of the most prevalent and disabling conditions worldwide, there’s no room […]

Read More
04.20.22

How to Improve Asthma Management

In America alone, 25 million people are living with asthma—one of the most common and costly diseases with no cure.1 This respiratory condition can be accompanied by transient or chronic symptoms that significantly impact quality of life. In the past, healthcare providers approached asthma treatment by focusing on the severity of a patient’s asthma. With […]

Read More
03.10.22

Scoring the SF-36v2® & SF-12v2® Health Surveys: Ranges for the Standard & Acute Versions

The SF-36v2® and SF-12v2® Health Surveys are patient-reported outcome (PRO) assessments designed to measure the quality of life and functional health and well-being of patients across a variety of health conditions. With data from these robust questionnaires, researchers, investigators, providers and other healthcare professionals can factor in the voice of the patient as they conduct […]

Read More
03.10.22

Assessing Asthma Control with Clinical Outcome Assessments

Although the healthcare community has made significant progress in understanding its pathophysiology and developing beneficial treatments to manage it, asthma remains a common condition linked with high mortality and social and economic effects.1 The symptoms of asthma, from chest tightness and shortness of breath to coughing and wheezing, can impact the everyday life of those […]

Read More
03.02.22

Measuring Health Outcomes in Clinical Research

Patient-centricity is paving a new path forward in the healthcare industry, changing the way we structure healthcare systems, deliver care and develop products. On a global scale, organizations are prioritizing the patient journey and shifting to value-based care as healthcare costs grow. These changes—along with other contributing factors—have placed a greater emphasis on outcome measurement.1 […]

Read More
02.21.22

QualityMetric Welcomes Tim Burks as Chief Technology Officer

RHODE ISLAND, February 21, 2022 ­­­— QualityMetric (QM), a technology-enabled provider of patient reported outcome (PRO) and clinical assessment outcome (COA) surveys, and consulting services, announced today the addition of Tim Burks as its newly-appointed Chief Technology Officer. Burks has joined the team led by Chief Executive Officer Garth “Gus” Gardner, who has been leading […]

Read More
10.28.21

Understanding Rare Cancers Using Patient-Reported Outcome Measures

Many fields in healthcare research benefit from leveraging clinician outcome assessments (COAs) to gain a deeper understanding of patient experiences. Patient-reported outcome (PRO) measures, or PROM, have seen an increased use over the years in clinical trials and other treatment delivery settings. These measurements paint a more complete picture of the spectrum of symptoms and […]

Read More
10.25.21

Understanding the Functions & Benefits of a Health Utility Survey & Index

Health providers require flexible tools for calculating health-related quality of life (HRQoL) with precision—and life sciences companies need innovative tools to prove value in the product lifecycle. Instruments for accomplishing both goals aren’t always widely applicable, convenient, straightforward or fully responsive to the health changes patients experience. This is why organizations across the healthcare continuum […]

Read More
10.04.21

The Increasing Importance of Linguistic Validation in the Healthcare Product Lifecycle

Rigorous and technical translation processes guide the development of content for a variety of products across the healthcare ecosystem. Patients, caregivers, clinicians, study site leaders and other key stakeholders rely on accurate information for research or care delivery in the pharmaceutical, biotechnology and medical device markets. Marketing finished endpoints, such as new drugs, therapies, treatment […]

Read More
09.30.21

QualityMetric and Survivor Healthcare enter a partnership to study unmet cognitive health needs of cancer patients.

Rhode Island — September 30, 2021 —QualityMetric, today announced a new partnership with Survivor Healthcare. The companies will be partnering to implement and measure an integrated program designed to improve cognitive functioning and overall health quality of life for cancer patients.

Read More
09.28.21

An In-Depth Guide to Patient-Reported Outcome Measures

Clinician-reported outcome (ClinRO) measures are the gold standard for assessing patient experiences in clinical research. Over the years, routine care and clinical research have benefitted from incorporating data derived directly from real patient experiences through patient-reported outcome (PRO) measures, also known as PROMs. PRO instruments are increasingly valued in clinical trial settings and treatment delivery, […]

Read More
09.14.21

QualityMetric’s SF-36v2 PRO Survey Contributes to EU’s ORCHESTRA SARS-CoV2 Impact Research

New York, September 14, 2021 — QualityMetric (QM), a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO), has announced its collaboration  in ORCHESTRA, a three-year international research project led by the University of Verona to measure the impact of the SARS-CoV2 pandemic. The project involves thirty-seven total partners […]

Read More
06.28.21

Pulse Infoframe and QualityMetric Partner to Develop Novel Rare Disease Solution

QualityMetric and Pulse Infoframe announced today their partnership and vision to create the first scientifically validated rare disease instruments across conditions. Once deployed, these instruments will benefit not only rare disease patients and families, but also researchers and drug developers working to help this vastly underserviced population as they advance rare disease care and treatments.

Read More
03.08.21

Vesey Street Capital Partners-Backed QualityMetric Adds Angela Host as Chief Commercial Officer

Ms. Host’s distinguished career spans 20+ years, with progressively larger leadership roles in healthcare across life sciences, provider, and payer markets.

Read More
01.29.21

Vesey Street Capital Partners-Backed QualityMetric Adds John Hart as Chief Financial Officer

Mr. Hart will join the team led by Chief Executive Officer Garth “Gus” Gardner, who has been in that role since soon after the VSCP-led recapitalization of the company in August of 2020.

Read More
01.07.21

QualityMetric Co-authors New Qualitative Study on hATTR

QualityMetric’s own Kimberly Raymond, Andrew Lovley, and Michelle White co-author a new study on the humanistic burden of hereditary transthyretin (hATTR) amyloidosis from the patient’s perspective.

Read More
12.30.20

QualityMetric Co-authors Study Supporting Content Validity of the ACT

QualityMetric’s Vice President and Senior Scientist, Mark Kosinski, co-authors a study for determining whether the content of the Asthma Control Test (ACT) serves as a valid measure of asthma control.

Read More
12.15.20

How We Identify the Best PRO Tools for Medical Device Manufacturers

Our experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.

Read More
11.15.20

QualityMetric Develops PROs for Determining Worldwide Impact of COVID-19

As pharma, biotech, medical device companies and academic researchers race to discover treatments for COVID-19, they require measurement and outcomes reporting for capturing real-world evidence.

Read More
09.15.20

A Letter to Our Customers

We want to inform you of a recent development that will allow us to enhance the services and support we provide.

Read More
09.11.20

Vesey Street Capital Partners Announces Gus Gardner as Chief Executive Officer of QualityMetric

Gardner’s appointment comes as the company seeks to build on its position as the preeminent provider of Patient Reported Outcomes (PRO) and Clinical Outcome Assessments (COA) solutions and services to healthcare and life sciences companies.

Read More